Well tolerated anticancer drug able to act on chemo-resistant tumors and to enhance the action of common chemotherapeutic drugs in association.
Proprietario: Fondazione IRCCS Istituto Nazionale dei Tumori
Monoclonal antibody with inhibitory activity on JMJD6 capable of inhibiting its interaction with collagen, counteracting the formation of fibrosis.
Antibody for diagnostic / staging and therapeutic purposes, if conjugated to markers for imaging or to toxins / radioactive isotopes.
Vectorial calculation applied to a decision-making matrix for the titration of the anesthesia levels
Control of the concentration of anaesthetic through a series of steps that allow to optimize the modulation of drugs.